China Life Insurance
VC Fund
Beijing, China
China Life Insurance is a VC fund in Beijing focused on Health Care and Medical. China's commercial insurance group.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries China Life Insurance invests in
Stages China Life Insurance invests in
Countries China Life Insurance invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 5 (36%)
- Medical 2 (14%)
- Biopharma 2 (14%)
- Logistics 2 (14%)
- Mobile Apps 2 (14%)
Stage
- Series A 4 (29%)
- Series B 2 (14%)
- Series C 2 (14%)
- Funding Round 2 (14%)
- Post-IPO Equity 2 (14%)
Country
- China 12 (86%)
- United States 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chen Fanglei
Chief Supervisor
|
Chief Supervisor | Total investments: 0 | Find email | |
|
Cui Lanqin
Vice President
|
Vice President | Total investments: 0 | Find email | |
|
Liu Huimin
Vice President
|
Vice President | Total investments: 0 | Find email | |
|
Miao Jianmin
Vice Chairman, President, Director
|
Vice Chairman, President, Director | Total investments: 0 | Find email | |
|
Wan Feng
Vice President
|
Vice President | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Saint Bella is a maternal and baby care center operator. | $15.8M / Series C / Mar 03, 2022 | |
|
|
China Mobile provides mobile telecommunications and related services in Mainland China and Hong Kong.Its portfolio of services comprises of local calls, domestic long distance calls, international long distance calls, intra-provincial roaming, inter-provincial roaming, and international roaming, caller identity display, caller restrictions, callwaiting, call forwarding, call holding, voice mail, conference calls, and others.In addition, the company offers data services, wireless data traffic services, telecommunications network planning design and consulting services, mobile data solutions, network planning and optimizing construction testing and supervising activities, technology support, designing and selling electronic communication products, and more.It was incorporated in 1997 and is based in Central, Hong Kong. China Mobile Limited is a subsidiary of China Mobile Hong Kong (BVI) Limited. | $3.8B / Post-IPO Equity / Dec 28, 2021 | |
|
|
METiS Pharmaceuticals is the world's first AI-driven drug formulation company. | $86M / Series A / Dec 13, 2021 | |
|
|
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation. | $86M / Series A / Dec 07, 2021 | |
|
|
Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions. | $188M / Series B / May 06, 2021 | |
|
|
Xinyi Energy is a solar farm operator in the PRC, mainly generates revenue from solar power electricity generation and sales of electricity to local subsidiaries of the State Grid, as well as receives management fees through the provision of operating and managing services of solar farms. All utility-scale solar farm projects owned by the Group arelocated in provinces with strong demand of electricity, such as Anhui Province, Hubei Province, Henan Province, Fujian Province and Tianjin Municipality, with no power curtailment problem ever in the past operating period. Currently, Xinyi Energy is owning a total of 16 solar farm projects with the aggregate approved capacity of 1,514 MW. Xinyi Energy intends to maintain a high dividend payout ratio. It's the Board's intention to declare and distribute not less than 90% of the distributable income for each financial year. | $115.2M / Post-IPO Equity / Sep 14, 2020 | |
|
|
Vazyme Biotech is devoted to the development and production of enzymes and antibodies. Our products cover clinical diagnosis, molecular diagnostics, high-throughput sequencing and life science research and other related fields. The company is located in the city of Nanjing, china's ancient capital of the Six Dynasties. Vazyme Biotech is in thefront of scenic Qixia mountain, dependent on the regional radiation force of the National Economic and Technological Development Zone of Nanjing. With advanced capability of R&D and cutting- edge technology, Vazyme Biotech will create a new pattern of National Biotechnology. | $78M / Series C / May 08, 2020 | |
|
|
JUSDA, a service platform of supply chain management for Foxconn Technology Group and a pilot in integrating C2C (Component to Consumer) supply chain services around the world, is committed to driving professionalism and growth of supply chain management by advanced technology and R&D. The company applies an innovative business model thatcovers trading flow, goods flow, information flow, capital flow, technology flow and process flow. | $340.2M / Series A / Jan 29, 2019 | |
|
|
JD Logistics is a technology-driven supply chain solution and logistics service provider in China. Jingdong Group began to build its own logistics in 2007, and officially established Jingdong Logistics Group on April 25, 2007. With the mission of "technology-driven, leading global efficient circulation and sustainable development", JDLogistics is committed to becoming the world's most reliable supply chain infrastructure service provider. | $2.5B / Feb 14, 2018 | |
|
|
United Imaging Healthcare develops and manufactures medical equipment and solutions. Its solutions cover areas of diagnostics, radiotherapy, and healthcare information technology solutions. United Imaging Healthcare offers medical imaging products such as computed tomography, molecular imaging, magnetic resonance, and X-ray radiography products,radiotherapy equipment, and uCloud UIH Intelligent Medical Cloud, a medical cloud platform for medical resource sharing and mass diagnostic data mining. It also provides customer, technical support, dispatching, and training services. United Imaging Healthcare began operation in 2011, with its headquarters in Shanghai in China. It has locations in Concord, Cleveland, Houston, Wuhan, and Shenzhen. | $467.8M / Series A / Sep 15, 2017 | |
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does China Life Insurance invest in?
China Life Insurance invests primarily in Health Care, Medical and Biopharma startups, most often at Series A and Series B stage. Most of the 14 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact China Life Insurance?
Public channels for China Life Insurance include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at China Life Insurance?
The team at China Life Insurance includes Chen Fanglei (Chief Supervisor), Cui Lanqin (Vice President) and Liu Huimin (Vice President), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!